Passion for People Development
NEWS
Selective mode in the wider AMP conversation.
2027 · AMR CONFERENCE, BASEL
Selmod will attend the AMR Conference in Basel, March 23-24, 2027.
Contact Dr. Frank Otto Gombert to schedule a meeting.
2026 · KAPITALBRUECKE BEIDER BASEL
Selmod attended the kickoff-event "Kapitalbrücke beider Basel". A big THANK YOU to the organizer for the great event and the successful exchange between founders and investors.
2026 · GAMRIC CONFERENCE
Derry Mercer attented the GAMRIC Conference in Lisbon, Portugal in September 2026.
Preclinical milestone: SLM500 in vivo proof of concept in resistant isolates
100% one-day survival in mice infected with a resistant clinical isolate to indicate the infection type and the genus and species of the bacteria used.
WHO 2024 bacterial priority patho-gens list - where Selmod's targets sit
The updated WHO list continues to prioritise carbapenem-resistant Gram-negatives. Two of our three programs sit directly on that shortlist.
Selmod at BIO-Europe Spring 2026 .........................
Meeting biotech investors and pharma BD teams across three days in Basel. Contact Frank Otto Gombert to schedule. ...........................................
Copyright© 2026 Selmod GmbH
All Rights Reserved.
